EDGAR Filing Documents for 0001144204-17-030892

Form 8-K - Current report:

SEC Accession No. 0001144204-17-030892

Filing Date

2017-06-02

Accepted

2017-06-02 17:28:49

Documents

Period of Report

2017-06-01

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v468249_8k.htm	8-K	39517
2	EXHIBIT 2.1	v468249_ex2-1.htm	EX-2.1	30986
3	EXHIBIT 3.1	v468249_ex3-1.htm	EX-3.1	5796
4	EXHIBIT 3.2	v468249_ex3-2.htm	EX-3.2	4358
5	EXHIBIT 3.3	v468249_ex3-3.htm	EX-3.3	37954
6	EXHIBIT 3.4	v468249_ex3-4.htm	EX-3.4	227026
7	GRAPHIC	pg1img1_ex3-1.jpg	GRAPHIC	187071
8	GRAPHIC	pg2img1_ex3-1.jpg	GRAPHIC	224563
	Complete submission text file	0001144204-17-030892.txt		914312

Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070

Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120

Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)